RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Gross margin (%)

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndGross margin (%) YoY (%)
Jun 30, 202559.4+4.74%
Jun 30, 202456.7+1.60%
Jun 30, 202355.8-1.40%
Jun 30, 202256.6-1.66%
Jun 30, 202157.5-0.97%
Jun 30, 202058.1-1.46%
Jun 30, 201959+1.28%
Jun 30, 201858.2+0.10%
Jun 30, 201758.1+0.25%
Jun 30, 201658-3.72%
Jun 30, 201560.2-5.36%
Jun 30, 201463.7+2.48%
Jun 30, 201362.1+3.57%
Jun 30, 201260+0.57%
Jun 30, 201159.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)